CALCISCON

calciscon-logo

Calciscon is a Swiss diagnostic company. Calciscon's aim is to become the leading company for the assessment, prevention and treatment of biomineralization-related medical problems.

#SimilarOrganizations #People #Financial #Website #More

CALCISCON

Industry:
Health Care Health Diagnostics Medical

Founded:
2013-01-01

Address:
Biel, Bern, Switzerland

Country:
Switzerland

Website Url:
http://www.calciscon.com

Total Employee:
1+

Status:
Active

Contact:
+41 32 530 88 60

Email Addresses:
[email protected]

Total Funding:
3.23 M CHF

Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag Microsoft Exchange Online


Similar Organizations

mediquo-logo

MediQuo

Spainโ€™s 24-hour, 7-day-a-week medical chat application.

xrapid-logo

xRapid

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Current Employees Featured

andreas-pasch_image

Andreas Pasch
Andreas Pasch President | Founder | CMO @ Calciscon
President | Founder | CMO
2013-08-01

vincent-linder_image

Vincent Linder
Vincent Linder Chief Executive Officer @ Calciscon
Chief Executive Officer
2019-12-01

Founder


andreas-pasch_image

Andreas Pasch

Investors List

yellowstone-holding_image

Yellowstone Holding

Yellowstone Holding investment in Series A - Calciscon

venturekick_image

Venture Kick

Venture Kick investment in Pre Seed Round - Calciscon

venturekick_image

Venture Kick

Venture Kick investment in Grant - Calciscon

venturekick_image

Venture Kick

Venture Kick investment in Grant - Calciscon

Official Site Inspections

http://www.calciscon.com

  • Host name: sl32.web.hostpoint.ch
  • IP address: 217.26.52.12
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "Calciscon"

CALCISCON

For example Calciprotein Particles are crucially involved in the progression of chronic kidney disease (CKD), and its resulting cardiovascular morbidity and mortality. Calciscon is initially โ€ฆSee details»

CALCISCON

Then please contact us. We look forward to hearing from you. CALCISCON AG Aarbergstrasse 46, 2503 Biel | Bienne. Switzerland Phone: 0041 32 530 88 60 Email: [email protected]See details»

Calciscon AG - BioAlps

Calciscon AG . Share this actor Commercializes a patented IVD blood test for patients with chronic kidney disease to functionally assess the tendency to calcify, reveal critical information โ€ฆSee details»

Calciscon - Crunchbase Company Profile & Funding

Organization. Calciscon . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Calciscon's vision is to improve the โ€ฆSee details»

CALCISCON

We offer a bundle package, under license contract, including non-routine reagents, equipment and software necessary for performing the T50: โ€ข T50 test kit containing plates, assay โ€ฆSee details»

CALCISCON AG Company Profile | Biel/Bienne, BERN, Switzerland ...

Find company research, competitor information, contact details & financial data for CALCISCON AG of Biel/Bienne, BERN. Get the latest business insights from Dun & Bradstreet.See details»

CALCISCON AG - VentureRadar

CALCISCON AG Follow Following Location: Switzerland. Founded in 2013. Privately Held. Develops innovative calcification blood tests, with secured IP and CE-marked scalable test kit. โ€ฆSee details»

Calciscon Company Profile 2024: Valuation, Funding & Investors

Calciscon was founded in 2013. Where is Calciscon headquartered? Calciscon is headquartered in Biel/Bienne, Switzerland. What is the size of Calciscon? Calciscon has 9 total employees. โ€ฆSee details»

Calciscon - Overview, News & Competitors | ZoomInfo.com

Calciscon - Business Information. Hospitals & Physicians Clinics · Switzerland · <25 Employees. CALCISCON is a privately held Swiss biotech company. Our aim: to become the leading โ€ฆSee details»

Calciscon - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Calciscon . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Calciscon has 2 โ€ฆSee details»

CALCISCON

Calciscon Announces Vincent Linder as CEO . The Board of Directors has appointed Vincent Linder as Chief Executive Officer (CEO). Dr. Pasch, co-founder and past-CEO, maintains his โ€ฆSee details»

CALCISCON European Union Trademark Information

Jan 30, 2023 The CALCISCON trademark was assigned an Application Number # 018692959 โ€“ by the European Union Intellectual Property Office (EUIPO). Trademark Application Number is โ€ฆSee details»

Calciscon AG - LinkedIn

Calciscon AG | 813 followers on LinkedIn. Calciscon develops and markets diagnostic devices for the assessment of calcification-related cardiovascular (CV) disease. CV disease is the leading โ€ฆSee details»

CALCISCON AG - Venture Kick

10.01.2023 Calciscon, Amsterdam University Medical Center, and Admesy to develop T50 test benchtop analyzer with EUR 2 million of Eurostars funding ... ORGANIZATION. Transforming โ€ฆSee details»

Calciscon - Crunchbase Company Profile & Funding

Calciscon's vision is to improve the cardiovascular risk management of kidney patients.See details»

CALCISCON

Please contact Calciscon at [email protected] for up-to-date information about reimbursement. 1: Bundy et al., CJASN 2019; 2: Keyzer et ...See details»

Calciscon - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. Calciscon . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. ... Calciscon has โ€ฆSee details»

CALCISCON

Please contact Calciscon at [email protected] and we will provide information on how to order your T50. You may also contact Dr. Pasch directly for an appointment at his office in Bern, โ€ฆSee details»

Calciscon enters Eurostars project to improve patient care worldwide

Jan 17, 2023 Based in Biel/Bienne (canton of Bern), Calciscon will lead the integration of the technology into an IVD-grade analyzer that will be tested in clinical settings at Amsterdam โ€ฆSee details»

CALCISCON

CALCISCON raises CHF 2.5M Series A to commercialize the T50 Test to drive more efficient therapies for renal patients Calciscon AG announced today the closing for its Series A โ€ฆSee details»

linkstock.net © 2022. All rights reserved